ES489929A0 - Procedimiento para preparar nuevos compuestos de quinolona - Google Patents

Procedimiento para preparar nuevos compuestos de quinolona

Info

Publication number
ES489929A0
ES489929A0 ES489929A ES489929A ES489929A0 ES 489929 A0 ES489929 A0 ES 489929A0 ES 489929 A ES489929 A ES 489929A ES 489929 A ES489929 A ES 489929A ES 489929 A0 ES489929 A0 ES 489929A0
Authority
ES
Spain
Prior art keywords
procedure
preparing new
quinolone compounds
new quinolone
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES489929A
Other languages
English (en)
Other versions
ES8104232A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of ES8104232A1 publication Critical patent/ES8104232A1/es
Publication of ES489929A0 publication Critical patent/ES489929A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES489929A 1979-03-27 1980-03-26 Procedimiento para preparar nuevos compuestos de quinolona Granted ES489929A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7910558 1979-03-27

Publications (2)

Publication Number Publication Date
ES8104232A1 ES8104232A1 (es) 1981-04-16
ES489929A0 true ES489929A0 (es) 1981-04-16

Family

ID=10504143

Family Applications (1)

Application Number Title Priority Date Filing Date
ES489929A Granted ES489929A0 (es) 1979-03-27 1980-03-26 Procedimiento para preparar nuevos compuestos de quinolona

Country Status (10)

Country Link
JP (2) JPS55130960A (es)
BE (1) BE882443A (es)
CY (1) CY1343A (es)
ES (1) ES489929A0 (es)
GB (1) GB2047691B (es)
GE (1) GEP19970835B (es)
JO (1) JO1072B1 (es)
MX (1) MX5950A (es)
SU (1) SU1124886A3 (es)
ZA (1) ZA801575B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
DE68917024D1 (de) * 1988-05-24 1994-09-01 Kirin Brewery 4(1H)-Chinolonderivate.
US8697674B2 (en) 2004-12-29 2014-04-15 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents

Also Published As

Publication number Publication date
GEP19970835B (en) 1997-02-10
GB2047691B (en) 1983-07-20
ZA801575B (en) 1981-03-25
ES8104232A1 (es) 1981-04-16
JPH0250086B2 (es) 1990-11-01
GB2047691A (en) 1980-12-03
BE882443A (fr) 1980-09-26
JPS62215526A (ja) 1987-09-22
JPS55130960A (en) 1980-10-11
JPH0114224B2 (es) 1989-03-10
SU1124886A3 (ru) 1984-11-15
CY1343A (en) 1987-01-16
MX5950A (es) 1993-11-01
JO1072B1 (en) 1982-07-10

Similar Documents

Publication Publication Date Title
AR231131A1 (es) Procedimiento para preparar acilureidoalquil-bencensulfonilureas
ES497884A0 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
MX154095A (es) Procedimiento para preparar polieteres sililados
MX5880E (es) Procedimiento para preparar derivados de bencilimidazol
ES492255A0 (es) Procedimiento para preparar aroilimidazol-2-onas
ES488635A0 (es) Procedimiento para preparar derivados de pirimidina
ES494119A0 (es) Procedimiento para preparar derivados de 3-aminoproxiarilo
MX6816E (es) Procedimiento para preparar quinolonas
ES488772A0 (es) Procedimiento para preparar derivados de pirimidona
AR226694A1 (es) Procedimiento para obtener nuevos derivados de antraciclina
BR8002698A (pt) Processos para preparacao de compostos
ES489689A0 (es) Procedimiento para preparar compuestos de isotiourea
MX7642E (es) Procedimiento para preparar la 1-ciclo-hexenilmentil-2-cloroetil pirrolidina
MX6141E (es) Procedimiento para preparar acil-ureas
ES496787A0 (es) Procedimiento de preparar compuestos triacinicos antialergi-cos
ES493499A0 (es) Procedimiento para preparar compuestos de 3-metilemazetidina
MX6024E (es) Procedimiento para preparar 2-cloro-4-hidroximetil-tiazoles-5-substituidos
MX6405E (es) Procedimiento para preparar tiazolilideno-oxo-propionitrilos
ES492394A0 (es) Procedimiento para preparar derivados de pirimidina
MX6971E (es) Procedimiento para preparar derivados de tetrahidroquinolina
ES489929A0 (es) Procedimiento para preparar nuevos compuestos de quinolona
ES495984A0 (es) Procedimiento para preparar compuestos de 6-metileno-morfi- nano
ES496518A0 (es) Procedimiento para preparar bencil-oximeteres trisustituidos
ES492692A0 (es) Procedimiento para preparar derivados de benoimidazol
MX6271E (es) Procedimiento para preparar n-ciandalquil haloacetamidas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990301